Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Israel Rico-Alba"'
Publikováno v:
Horizonte Sanitario, Vol 21, Iss 2, Pp 194-203 (2022)
Objetivo: Evaluar los factores relacionados con el uso del Expediente Clínico Electrónico (ECE) desde la percepción de los usuarios médicos y enfermeras de los servicios de salud de un hospital de 2do nivel en Morelos, México. Material y método
Externí odkaz:
https://doaj.org/article/bfe5f8f6aee24240ab86b75f1d36ffd5
Autor:
Israel Rico-Alba, Albert Figueras
Publikováno v:
British Journal of Clinical Pharmacology. 78:410-421
Aims The aims were to analyze the dynamics of the medicines formulary in a middle-income country and to analyze the concordance of the included medicines with the national Clinical Practices Guidelines (CPG). Methods Medicines and their indications o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0a6a0eb8bd54113cba2c32d6c4cb5cc
https://doi.org/10.1111/bcp.12337
https://doi.org/10.1111/bcp.12337
Autor:
Israel, Rico-Alba, Albert, Figueras
Publikováno v:
British journal of clinical pharmacology. 78(2)
The aims were to analyze the dynamics of the medicines formulary in a middle-income country and to analyze the concordance of the included medicines with the national Clinical Practices Guidelines (CPG).Medicines and their indications of use included
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ab77cdcc4127962f485a986fb699b655
https://pubmed.ncbi.nlm.nih.gov/25099259
https://pubmed.ncbi.nlm.nih.gov/25099259
Autor:
Albert Figueras, Israel Rico-Alba
Publikováno v:
European journal of clinical pharmacology. 69(4)
To assess the rationality of the Mexican Formulary List (MEX-LIST). MEX-LIST was compared with the World Health Organization Essential Medicines List (WHO-LIST) to identify drugs classified as unmet needs. For the MEX-LIST rationality evaluation, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70cd8fd82804b04eabd514a51b279fc1
https://pubmed.ncbi.nlm.nih.gov/23090699
https://pubmed.ncbi.nlm.nih.gov/23090699
Publikováno v:
Value in Health Regional Issues. :40-47
Objective To assess the cost-utility of collagen-polyvinyl pyrrolidone (collagen-PVP), a new drug developed and manufactured in Mexico, compared to non-steroidal anti-inflammatory drugs in the treatment of patients with knee osteoarthritis (OA) in Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c2005326bc3a3c5208e41eed34724a6